Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PharmaPrint

This article was originally published in The Tan Sheet

Executive Summary

Company begins tests to standardize soy's active ingredients and total bioactivity. The Irvine, Calif.-based firm says it is using the same process by which it developed the Centrum Herbals line for American Home Products

You may also be interested in...



PharmaPrint Moving Toward In-House Manufacturing Capability

PharmaPrint is consolidating its manufacturing operations through an agreement with the contract manufacturer Lone Star Pharmaceuticals, the dietary supplement developer and marketer announced Aug. 16. The deal will serve as a stepping stone toward the construction of an in-house PharmaPrint production and laboratory facility.

PharmaPrint Moving Toward In-House Manufacturing Capability

PharmaPrint is consolidating its manufacturing operations through an agreement with the contract manufacturer Lone Star Pharmaceuticals, the dietary supplement developer and marketer announced Aug. 16. The deal will serve as a stepping stone toward the construction of an in-house PharmaPrint production and laboratory facility.

PharmaPrint Moving Toward In-House Manufacturing Capability

PharmaPrint is consolidating its manufacturing operations through an agreement with the contract manufacturer Lone Star Pharmaceuticals, the dietary supplement developer and marketer announced Aug. 16. The deal will serve as a stepping stone toward the construction of an in-house PharmaPrint production and laboratory facility.

Topics

UsernamePublicRestriction

Register

PS090137

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel